Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06116526 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Dupilumab De-escalation in Pediatric Atopic Dermatitis

StatusRecruiting
PhasePhase 4
Started2024-04-01
View on ClinicalTrials.gov ↗

Amendment history

2026-04-17
Study Status v8
Primary completion pushed: 2026-04-01 → 2027-04-01
2026-01-12
Study Status, Contacts/Locations v7
Study sitescontacts updated at 1 of 1 site
2026-01-09
Study Status, Contacts/Locations v6
Re-verified, no change to tracked fields
2025-01-13
Study Status, Contacts/Locations v5
Study sitescontacts updated at 1 of 1 site
2024-04-09
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v4
Trial statusNot Yet Recruiting→Recruiting
Study sites0→1
Show 3 earlier versions
2024-03-12
Study Status v3
Primary completion date2026-09-01→2026-04-01
Completion date2027-12-31→2027-04-30
Start date2024-03-01→2024-04-01
2024-01-17
Study Status v2
Start date2024-01-01→2024-03-01
2023-11-02
Study Identification, Study Status v1
Study title-15 characters
Dupilumab De-escalation in Pediatric Atopic Dermatitis: A Pilot Trial
2023-10-30
Original filing
This is a pilot investigator-blinded, randomized clinical trial to assess the feasibility of dupilumab treatment discontinuation or dose-reduction in children aged 1-17 years who have achieved sustained atopic dermatitis (AD) control on dupilumab.
Trial Details
NCT Number NCT06116526
Lead Sponsor Johns Hopkins University
Collaborators: Doris Duke Charitable Foundation
Conditions Atopic Dermatitis
Enrollment 30 participants
Start Date 2024-04-01
Primary Completion 2027-04-01 (estimated)
Study Completion 2027-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-20